First patient dosed in pivotal phase II FIREFLY-1 study of DAY-101 in pediatric low-grade glioma May 12, 2021
First patient dosed in phase I/II study of CBX-12 in advanced or metastatic refractory solid tumors May 11, 2021
RSS